Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2019 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
victor goldberg
(90 results)?
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630.
N Engl J Med. 2019.
PMID: 30786186
Clinical Trial.
Phase I Clinical Trial Using [99mTc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients.
Chernov V, Dudnikova E, Zelchan R, Medvedeva A, Rybina A, Bragina O, Goldberg V, Muravleva A, Sörensen J, Tolmachev V.
Chernov V, et al. Among authors: goldberg v.
Pharmaceutics. 2022 Jun 15;14(6):1274. doi: 10.3390/pharmaceutics14061274.
Pharmaceutics. 2022.
PMID: 35745847
Free PMC article.
Item in Clipboard
B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study.
Tashireva LA, Popova NO, Kalinchuk AY, Goldberg VE, Kovalenko EI, Artamonova EV, Manikhas AG, Ponomarenko DM, Levchenko NV, Rossokha EI, Krasilnikova SY, Zafirova MA, Choynzonov EL, Perelmuter VM.
Tashireva LA, et al. Among authors: goldberg ve.
Front Oncol. 2022 Jun 23;12:909505. doi: 10.3389/fonc.2022.909505. eCollection 2022.
Front Oncol. 2022.
PMID: 35814376
Free PMC article.
Item in Clipboard
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
Coiffier B, Osmanov EA, Hong X, Scheliga A, Mayer J, Offner F, Rule S, Teixeira A, Walewski J, de Vos S, Crump M, Shpilberg O, Esseltine DL, Zhu E, Enny C, Theocharous P, van de Velde H, Elsayed YA, Zinzani PL; LYM-3001 study investigators.
Coiffier B, et al.
Lancet Oncol. 2011 Aug;12(8):773-84. doi: 10.1016/S1470-2045(11)70150-4. Epub 2011 Jul 1.
Lancet Oncol. 2011.
PMID: 21724462
Clinical Trial.
Item in Clipboard
Cite
Cite